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ABSTRACT
Queuosine (Q) was discovered in the wobble po-
sition of a transfer RNA (tRNA) 47 years ago, yet
the final biosynthetic enzyme responsible for Q-
maturation, epoxyqueuosine (oQ) reductase (QueG),
was only recently identified. QueG is a cobalamin
(Cbl)-dependent, [4Fe-4S] cluster-containing protein
that produces the hypermodified nucleoside Q in situ
on four tRNAs. To understand how QueG is able
to perform epoxide reduction, an unprecedented re-
action for a Cbl-dependent enzyme, we have deter-
mined a series of high resolution structures of QueG
from Bacillus subtilis. Our structure of QueG bound
to a tRNATyr anticodon stem loop shows how this
enzyme uses a HEAT-like domain to recognize the
appropriate anticodons and position the hypermodi-
fied nucleoside into the enzyme active site. We find
Q bound directly above the Cbl, consistent with a re-
action mechanism that involves the formation of a
covalent Cbl-tRNA intermediate. Using protein film
electrochemistry, we show that two [4Fe-4S] clusters
adjacent to the Cbl have redox potentials in the range
expected for Cbl reduction, suggesting how Cbl can
be activated for nucleophilic attack on oQ. Together,
these structural and electrochemical data inform our
understanding of Cbl dependent nucleic acid modifi-
cation.
INTRODUCTION
To date, more than 100 post-transcriptional modifications
of transfer RNA (tRNA) have been reported (1,2). These
modifications appear to stabilize local tRNA structure and,
when found in the wobble position of the anticodon, en-
sure control over specificity and/or efficiency of transla-
tion (3,4). One of the more impressive hypermodifications
is represented by queuosine (Q) (Figure 1A and B) (5,6),
an RNA nucleoside that was discovered 47 years ago in
the course of sequencing tRNATyr from Escherichia coli (7–
9). This unusual nucleoside and its analogs (Supplementary
Figure S1) were subsequently found in the wobble position
of tRNAAsp, tRNAAsn, tRNAHis and tRNATyr (G/Q-U-N
anticodons) and shown to be present in a wide range of or-
ganisms from bacteria to man (8,10–12). Notably, archaea
contain the structurally related hypermodified RNA nucle-
oside archaeosine (13), which is found within the D loop
of archaeal tRNAs at position 15 rather than at the wob-
ble position. Q is only biosynthesized by bacteria and is
obtained by mammals from dietary sources or microbes in
the gut (14). It is not essential under normal growth con-
ditions in E. coli, but appears to confer selective advantage
when a wild-type strain is grown in competition with a vari-
ant lacking Q (15). In mice, depletion of Q from dietary
sources leads to neurological defects and death. More gen-
erally, hypomodified cellular RNA pools are correlated with
cancer progression and viral infection (14).
The biosynthetic pathway for Q was recently elucidated
(16–21) (Figure 1A) and the enzyme responsible for the fi-
nal step identified and biochemically characterized (19,22).
Epoxyqueuosine (oQ) reductase (QueG) catalyzes the re-
duction and dehydration of an oQ moiety that is already
incorporated in the wobble position of tRNA (oQ-tRNA)
to yield Q-tRNA (19). Surprisingly, QueG is not homol-
ogous to other tRNA modifying enzymes but instead is
a cobalamin (Cbl, vitamin B12)/[4Fe-4S] protein (19) that
is similar to CblC, an enzyme that catalyzes the reduc-
tive decyanation/dealkylation of Cbl derivatives (23,24). It
is also similar to the reductive dehalogenase (RDH) fam-
ily of enzymes (19,25–27), which degrade both environ-
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Figure 1. Queuosine biosynthesis and incorporation into four tRNAs. (A) Scheme for the conversion of GTP to Q. (B) Diagram of tRNA that includes
the nucleotide sequence of the anticodon stem loop construct of tRNATyr that was used in this work. Incorporation of Q in the wobble position of tRNA
enables decoding of substrate codons with either a corresponding U or C in the 3′ codon position.
mental and human-introduced organohalides such as tetra-
chloroethene (28). Cbl-enzymes are generally referred to
as having two flavors: ones that use a methylcobalamin
(MeCbl) cofactor and catalyze methyl transfer reactions,
and ones that use adenosylcobalamin (AdoCbl) and cat-
alyze radical-mediated rearrangement reactions; yet QueG
and RDHs do not appear to use either of these Cbl deriva-
tives (29). Here, we present crystal structures of QueG from
Bacillus subtilis, both alone and in complex with tRNA, in
order to visualize how a Cbl-dependent enzyme can modify
RNA.
MATERIALS AND METHODS
All crystallography experiments were performed under
anaerobic conditions within either a 95–97% Ar and 3–5%
H2 atmosphere in a Coy anaerobic chamber, or a purely
N2 atmosphere within an MBraun anaerobic chamber. All
materials and solutions used for purification were deoxy-
genated in the anaerobic chambermany days prior andwere
RNase-free when possible. Crystallization-grade reagents
were purchased from Hampton Research and purged with
Ar prior to use. Small aliquots of <0.1 ml were flash
frozen and exposed to vacuumbefore being brought into the
anaerobic chambers. RNase-free crystallization trays were
generated aerobically, flash frozen, exposed to vacuum and
allowed to gas exchange while covered with crystallization
tape in an anaerobic chamber overnight prior to crystalliza-
tion. QueG was purified and reconstituted under anaerobic
conditions in a Coy anaerobic chamber containing a 95–
97% N2 and 3–5% H2 atmosphere.
Detection of RNase activity in QueG protein samples
We were surprised to find no electron density for the anti-
codon bases of the unmodified tRNA anticodon stem loop
(ACSL). This lack of density suggested to us that low levels
of RNase contamination in the purified protein could have
clipped the RNA. RNase contamination during protein pu-
rifications is a known issue (30) that may be exacerbated at
the concentrations of protein/RNAused in crystallography.
Whereas dilute assays may show little-to-no RNase con-
taminating activity, concentrated samples may contain high
enough RNase levels to observe RNA degradation. Over
the course of a crystallization experiment, this contaminat-
ing activity may result in total loss of the desired RNA sam-
ple. To test for contamination, total E. coli RNA samples,
enriched for tRNA, were incubated with QueG (expressed
and purified as detailed below) and monitored for RNase
activity. QueG (150 M) and RNA (70 M) were mixed
and incubated at 37◦C for 3 h, with a control in which only
QueG buffer was added to the RNA sample. Formamide-
containing loading dye was added to each sample, and sam-
ples were then frozen and thawed prior to analysis by 8%
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PAGE/7M urea. Gels show that addition of the QueG pro-
tein sample to the RNA leads to substantial RNA degra-
dation (Supplementary Figure S2A), suggesting the pres-
ence of a contaminating RNase. Murine RNase inhibitor
(NEB), which inhibits RNases A, B and C by binding in
a 1:1 stoichiometric ratio, was incubated with RNA/QueG
mixtures at 4, 0.4, 0.04, 0.004 and 0.0004 units, at 37◦C for 3
h. RNA degradation levels were analyzed by 7 M urea/8%
PAGE and were found to be greatly diminished as a re-
sult of theRNase inhibitor addition (Supplementary Figure
S2B). The observed decrease in RNase activity suggested
that the observed RNA degradation was due to an RNase
A-, B- or C-type contamination, with RNase A as a likely
culprit. To minimize RNA degradation by A-, B- and C-
type RNases, we began using RNase-free reagents (see be-
low) during the protein preparation and took extra precau-
tions in handling glassware. We also switched to expressing
QueG inBL21(DE3)Δrna, which contains a deletion for the
RNase I gene. The generation of BL21(DE3)Δrna has been
described in Supplementary Data for reference (31). QueG
produced and purified in this manner showed no detectable
RNase activity when assayed as described above (data not
shown).
Expression and purification of SeMET-labeled QueG and
wild-type B. subtilis QueG
A construct of B. subtilis QueG in the pASK-IBA43plus
vector (IBA), containing an N-terminal hexahistidine tag
and a C-terminal Strep-tag II, was utilized for expression
and purification (22). Selenomethionine (SeMET)-labeled
QueG was obtained by growth in minimal media using a
method to suppress methionine biosynthesis (32). Wild-
type B. subtilis QueG was expressed recombinantly us-
ing two different E. coli cell lines. Initially, BL21(DE3)
cells were used as previously described (22). After the
discovery of RNase contamination of QueG samples, all
disposable materials used were certified RNase-free. All
non-disposable materials and glassware were treated with
RNaseZap (Applied Biosystems) according to the man-
ufacturer’s protocol prior to use. RNase-free water was
made by adding diethyl pyrocarbonate to MilliQ water
to a final volume of 0.05% (v/v) followed by incubation
overnight at room temperature, with subsequent autoclav-
ing the next day. All buffers/solutions were then made us-
ing the RNase-free water. Additionally, the cell line was
switched to BL21(DE3)Δrna, which contains a deletion for
the RNase I gene (see Supplementary Data in reference
(31)).
Both wild-type and SeMET-labeled QueG were purified
as follows. Cells (∼20 g) were suspended in buffer contain-
ing 50 mM Tris-HCl (pH 7.6), 0.5 M NaCl, 20 mM im-
idazole, 0.5 mM dithiothreitol (DTT) and 1 mM phenyl-
methylsulfonyl fluoride and disrupted using a Branson digi-
tal sonifier (45% amplitude). The lysate was centrifuged for
20 min at 18 000 ×g (4◦C) to pellet insoluble lysate. The
cleared lysate was loaded onto a 5 ml HisTrap HP column
(GE Healthcare), which had been charged with NiSO4 and
equilibrated with a buffer containing 50 mM Tris-HCl (pH
7.6), 0.5 M NaCl, 20 mM imidazole (buffer A). The col-
umn was then washed with 25 ml of buffer A, and QueG
was eluted with 25 ml of buffer A containing 0.75 M imi-
dazole. Fractions containing QueG were pooled based on
analysis by SDS-PAGE and then buffer exchanged using
a BioRad DG-10 column into 100 mM Tris-HCl (pH 8.0)
and 150mMNaCl (buffer B). The protein was subsequently
loaded onto a 5 ml StrepTrap HP column (GE Healthcare)
that had been equilibrated with buffer B. The column was
then washed with 25 ml of buffer B and QueG was eluted
with 25 ml of buffer B containing 2.5 mM d-desthiobiotin
(Sigma Aldrich). Fractions containing QueG were again
identified using SDS-PAGE and pooled. The protein was
reconstituted with its two [4Fe-4S] clusters in a Coy anaer-
obic chamber as described previously (22). The reconsti-
tuted protein solution was buffer exchanged using a Bio-
Rad DG-10 column into 20 mM Tris-HCl (pH 8.0), 100
mM KCl and 2 mM DTT (buffer C), and concentrated to
a final volume of less than 1 ml by centrifugation at 6000
×g (4◦C) using an Amicon Ultra-4 10 kDa cutoff concen-
trator. One hundred microliters of 20 mM hydroxocobal-
amin acetate salt (Sigma-Aldrich) was added to the result-
ing concentrated [4Fe-4S]-QueG, and after a 5 min incu-
bation period at room temperature, the protein was loaded
onto a column packed with Sephacryl S300 HR resin (GE
Healthcare) equilibrated in buffer C, and eluted at a con-
stant flow rate of 1 ml min−1 as previously described (22).
Following SDS-PAGE, fractions were pooled and concen-
trated by centrifugation at 4000 ×g (4◦C) using an Amicon
Ultra-15 10 kDa cutoff concentrator. Protein concentration
was assessed using the Bradford method. Protein aliquots
were frozen in liquid N2 and stored at −80◦C.
Protein film electrochemistry
Experiments were performed anaerobically in an MBraun
Labmaster glovebox using a PGSTAT 12 potentiostat (Eco-
Chemie) using the tagged B. subtilisQueG protein. A three-
electrode configuration was used with a standard calomel
reference electrode, a platinum wire counter electrode and
a pyrolytic graphite edge (PGE) working electrode in a
water-jacketed glass cell. The electrochemical cell was ther-
mostated using a circulating water bath and the reference
electrode wasmaintained at room temperature in the course
of the experiments. Potentials reported are relative to the
standard hydrogen electrode.
Baseline measurements were collected using the PGE
electrode polished with 1 M alumina, rinsed and placed
into the cell containing a 10◦C mixed buffer solution com-
posed of 10 mM MES, CHES, TAPS, HEPES, at pH 8.0
with 200 mM NaCl. A 3 l sample of 340 M protein was
applied directly to the polished PGE electrode surface, the
protein sample was removed after 3 min, and the electrode
was immediately placed back into the cell solution. Non-
turnover electrochemical signals were analyzed by correc-
tion of the non-Faradaic component of the current from the
raw data using the SOAS package (33).
Crystallization
Crystallization of tagged and SeMET-labeled B. subtilis
QueG was performed in an MBraun chamber under a ni-
trogen environment. Initial crystallization conditions were
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obtained using a Mosquito pipetting robot (TTP Factory)
within this chamber. Optimized crystallization conditions
were obtained in the same anaerobic chamber by using
sitting drop vapor diffusion method at 21◦C, mixing 0.5
l protein (150 M SeMET-labeled QueG [6.5 mg ml−1],
20 mM Tris (pH 8.0), 100 mM KCl, 10 mM DTT) with
1.5 l of reservoir solution (0.1 M acetate (pH 4.5), 0.4
M (NH4)H2PO4, 12% (w/v) PEG 3350) and equilibrat-
ing against 600 l of reservoir solution. Optimal SeMET-
labeled QueG crystals of 100 × 100 × 50 m3 dimensions
grew within two to three weeks and were transferred to a
25◦C polyvinyl anaerobic chamber (Coy Lab) under 95%
Argon/5% hydrogen atmosphere. Crystals were harvested,
cryoprotected in reservoir solution supplemented with 20%
(v/v) glycerol, and cryocooled in liquidN2 within the anaer-
obic chamber.
Crystals that generated structures of QueG bound to a
cleaved ACSL (see Supplementary Table S2) were obtained
through co-crystallization experiments that employed 150
M [6.5 mg ml−1] of wild-type QueG in 20 mM Tris (pH
8.0), 100 mMKCl and 10 mMDTT, and 375 M of a con-
struct of the E. coli tRNATyr ACSL (5′-G-C-A-G-A-C-U-
G-U-A-A-A-U-C-U-G-C-3′) (IDT) (Supplementary Fig-
ure S3) and the same crystallization conditions detailed
above. These crystals were transferred to theCoyLab anaer-
obic chamber and either cryoprotected with 20% (v/v) glyc-
erol or 20% (v/v) PEG 400 and flash cooled in liquid N2
within the chamber.
Crystals that generated a structure of QueG bound to
an intact ACSL were obtained in the MBraun anaerobic
chamber through co-crystallization of 150 M wild-type
QueG (purified from BL21(DE3)Δrna cells and stored in
20 mM Tris (pH 8.0)), 100 mM KCl, 10 mM DTT, and
375 M of oQ-modified substrate (5′-G-C-A-G-A-C-U-
oQ-U-A-A-A-U-C-U-G-C-3′) that was generated as previ-
ously described (19). In addition to the methods mentioned
above for minimizing the amount of RNase contamina-
tion in the enzyme samples, murine RNase inhibitor (0.006
units) was added to the co-crystallization experiment as a
preventative measure to preserve the RNA substrate. The
QueG-ACSL complex crystallized under the same condi-
tions as detailed above and was cryoprotected with 20%
PEG 400 and flash cooled in liquid N2 within the Coy Lab
anaerobic chamber.
Data collection, structure solution and refinement
SeMET-labeled QueG crystallized with two molecules per
asymmetric unit (Vm of 2.6 A˚3 Da-1 and solvent content of
53%). These crystals diffracted to 1.75 A˚ resolution (Sup-
plementary Table S1). Anomalous peak, inflection and re-
mote data sets of SeMET-labeled QueG were collected at
0.9793 A˚, 0.9795 A˚ and 0.9421 A˚ wavelengths at 100 K
to phase the structure. Data were collected at beamline
24ID-C at theAdvanced Photon Source (ArgonneNational
Labs, Argonne, IL, USA) using a Pilatus 6M detector and
minikappa to align Friedel Mates (34) and processed us-
ing HKL2000 (35). Sixteen initial heavy atom sites, cor-
responding to eight selenomethionines per molecule, were
determined using SHELXC and given to AutoSol in the
PHENIX suite of programs (36,37). A solution was found
in AutoSol using the peak, inflection and remote data sets
with a figure-of-merit of 0.57 to 2.5 A˚ resolution. Experi-
mental maps at 2.5 A˚ resolution enabled direct building of
one protein molecule and nicely revealed the locations of
all cofactors (Cbl and two [4Fe-4S] clusters). Pure transla-
tional non-crystallographic symmetry (NCS) was used to
generate the second protein molecule within the asymmet-
ric unit. Iterative rounds of refinement in PHENIX (37)
and model building in COOT (38) were carried out. Re-
finement was conducted against the full resolution of data
using NCS restraints (simulated annealing, positional and
B-factor refinement). The cobalamin parameter file for re-
finement was provided by O. Smart at Global Phasing, and
the parameter file for iron–sulfur clusters was generated us-
ing phenix.elbow (39) and the high resolution structures of
the HydE protein (40). NCS restraints were gradually re-
leased during refinement, and waters, glycerols and phos-
phate ions were added in the later rounds of refinement.
The final model refined without NCS restraints was verified
by simulated annealing composite omit maps calculated in
CNS (41), and the model’s geometry was checked and vali-
dated using ProCheck and MolProbity (42,43). Analysis of
the calculatedRamachandran Plot statistics fromProCheck
held 93.2% of residues in the most favored regions, with
6.5% in favored and 0.3% in disallowed (corresponding to
Asp134 of the active site). The refined protein model con-
tains residues 2–385 and 2–376 for molecules A and B, re-
spectively. Glu125 has poor density. Less than 811 A˚2 inter-
face surface area is calculated between the twomolecules us-
ing the PISA server (44) compared to a total surface area of
16 970 A˚2, which is consistent withQueG being amonomer.
Data for the 2.10 A˚ resolution structure of QueG with
a cleaved ACSL (Supplementary Table S2) were collected
at beamline 24ID-C at a wavelength of 0.9792 A˚ and tem-
perature of 100 K. The structure was solved by molecular
replacement (MR) in PHASER (45) using themodel of 1.75
A˚ resolution SeMET-labeled QueG minus ligands and wa-
ter molecules. The MR solution yielded a final LLG value
of 21 243 for the 2.1 A˚ resolution structure with four QueG
molecules per asymmetric unit. Refinement and model
building were carried out similarly to that described above.
RNA and phosphates were built into the electron density
and waters were added in the later rounds of refinement.
The final model (Supplementary Table S2) refined without
NCS restraints was verified by simulated annealing com-
posite omit maps calculated in CNS and PHENIX (37,41),
and the model’s geometry was checked and validated us-
ing ProCheck and MolProbity (42,43). As in the SeMET-
labeled QueG structure, the refined protein model contains
residues 2–381, 2–381, 2–378 and 2–377 for molecules A,
B, C and D, respectively, with residue Glu125 disordered in
all protein molecules. Additionally, the side chain of Arg86
exhibits no electron density in molecules A and B and was
omitted from the structure. Electron density for RNA en-
abled building of RNA interacting with QueG monomers
A (13 nucleotides: G27–U33 and A38–C43) and B (11 nu-
cleotides: A29–U33 and A37–G42); QueG monomers C
andDdo not bindRNAand have glycerol boundwithin the
enzyme active site. Phosphate ions are observed in identical
positions with respect to the SeMET-labeled QueG struc-
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ture. Ramachandran statistics from ProCheck are as fol-
lows: 92.6% most favored; 7.1% favored; and 0.3% allowed.
Data for the 2.65 A˚ resolution structure of QueG with
a cleaved ACSL (Supplementary Table S2) were collected
at beamline 24ID-C (Supplementary Table S2) at a wave-
length of 0.9795 A˚ and temperature of 100 K. This struc-
ture was solved by molecular replacement using the soft-
ware PHASER (45) and the 1.75 A˚ resolution SeMET-
labeled QueG structure, minus ligands and water molecules,
as the search model. Two molecules of QueG were located
with a final LLG value of 3668. Rounds of simulated an-
nealing, positional and B-factor refinement were performed
in PHENIX (37) using NCS restraints and parameter files
described above. Refinement rounds were conducted itera-
tively with model building in COOT (38). NCS restraints
were gradually released, and RNA, phosphates and wa-
ter molecules were added in the later rounds of refine-
ment. The final model (Supplementary Table S2) refined
without NCS restraints was verified by simulated anneal-
ing composite omit maps calculated in CNS and PHENIX
(37,41), and the model’s geometry was checked and val-
idated using ProCheck and MolProbity (42,43). The re-
fined protein model contains residues 2–375 for molecule
A, and 2–132 and 136–376 for molecule B. Notably, the
Asp134-containing loop displays weaker electron density in
a ‘flipped-out’ conformation in molecule A, and this loop
is disordered in molecule B and could not be built into
the model. Electron density for RNA nucleotides interact-
ing with monomer B enabled refinement of A29–U33, al-
though only three phosphate groups for the complementary
bases are observed and built into the structure. A phosphate
ion was also observed within the active site of both protein
molecules A and B near their respective cobalamins, and
crystallographic packing phosphates are observed in iden-
tical positions as in the SeMET-labeledQueG structure. Ra-
machandran statistics from ProCheck are as follows: 91.0%
most favored; 8.7% favored; 0.2% allowed; and 0.2% disal-
lowed (Asp134 in the ‘flipped out’ conformation).
Data for the structure of QueG with an intact ACSL
(Supplementary Table S2) were collected on two differ-
ent crystals at the Stanford Synchrotron Radiation Light-
source, beamline 12-2, at a wavelength of 0.9795 A˚ and tem-
perature of 100 K on a Pilatus 6M detector. Data from two
crystals were then merged to create a 92.8% complete data
set at 2.65 A˚ resolution. The structure was solved to 2.65
A˚ resolution by MR in PHASER (45) using the 1.75 A˚ res-
olution SeMET-labeled QueG structure minus ligands and
water molecules as an initial search probe. An LLG value
of 3795 with two QueG molecules in the asymmetric unit
was obtained. Iterative rounds of refinement in PHENIX
(37) were paired with model building in COOT (38) as de-
scribed above. Also as above, the RNA and waters were
added in the later stages of refinement. The parameter file
for queuosine and epoxyquouosine were generated using
SMILES notation in the Grade Web Server (http://grade.
globalphasing.org). The final model was verified by sim-
ulated annealing composite omit maps calculated in CNS
and PHENIX (37,41), and themodel geometry was checked
and validated using ProCheck and MolProbity (42,43). An
intact ACSL binds to QueG in molecule A only, and glyc-
erol binds within the active site of molecule B. Phosphate
ions are observed that are identical to the SeMET-labeled
QueG structure. Both proteinmolecules contain residues 2–
377, except that Glu125 is completely disordered and omit-
ted from molecule B. The full RNA ACSL (17 nucleotides:
G27–C43) is built and refined in the model. Ramachandran
statistics fromProCheck are as follows: 92.9%most favored;
6.8% favored; and 0.3% allowed.
In this structure of QueG with an intact ACSL, the elec-
tron density within the active site is best fit as the prod-
uct, queuosine (Supplementary Figure S4A). In particular,
there is no electron density for the epoxide oxygen in the
omit 2mFo-DFc electron density map (Supplementary Fig-
ure S4B). The presence of Q is consistent with the fact that
the QueG:oQ ACSL complex is fully loaded and ready for
catalysis; requiring only electrons. Upon X-ray exposure
during data collection, it is possible that QueG is able to
convert the oQ substrate into the product, queuosine. The
refined product complex contains Q at full occupancy, with
B-factor values comparable to other residues and cofactors
within the active site (Supplementary Table S2).
Composite omit maps and simulated annealing omit
maps for figures were generated using PHENIX and CNS
(37,41). Figures were created using PyMOL, electrostatics
were calculated using the APBS plugin (46), and the topol-
ogy diagram was generated using TopDraw (47).
RESULTS
Structure of B. subtilis QueG reveals a modular fold with a
base-off Cbl and two [4Fe-4S] clusters
Structural data were obtained from recombinant B. subtilis
QueG that was reconstituted with hydroxocob(III)alamin
and two [4Fe-4S] clusters and shown to be active in end-
point assays examining conversion of oQ into Q (19). The
crystal structure was determined to 1.75 A˚ resolution us-
ing SeMET-labeled QueG and the multiwavelength anoma-
lous dispersion method (Supplementary Table S1). As was
observed recently for a QueG homolog from Streptococcus
thermophilus (27), QueG contains three functional domains
that bind Cbl, the [4Fe-4S] clusters and tRNA, respec-
tively (Figure 2 and Supplementary Figure S5). The Cbl-
binding domain at the N-terminus (Asn2 – Ser189) adopts
an −− sandwich fold with a central, four-stranded an-
tiparallel -sheet and a peripheral -hairpin. A ferredoxin-
like domain (Fd-domain) (Ser190 – Leu256) follows that
binds the two [4Fe-4S] clusters. The RNA-binding domain
(Leu257 – Leu385) is at the C-terminus and consists of an
antiparallel six-helical bundle with a small helix (8b) in-
serted after the first helix (8a). This antiparallel helical
bundle resembles a HEAT domain, a scaffold that typically
serves to mediate protein–protein or protein–RNA/DNA
interaction (48), and rests on two extended loops from the
Cbl-binding (Cbl-insert; Tyr77 – Asp104) and Fd-domain
(Fd-insert; Ile215 – Gly239) domains, respectively.
Consistent with electron paramagnetic resonance (EPR)
measurements (22), 5-coordinate Cbl is bound to QueG
with water as the upper axial ligand (Supplementary Fig-
ure S5C). The Cbl-binding domain of QueG is structurally
similar to CblC (Supplementary Figure S6) and to RDH
enzymes, PceA from Sulfurospirillum multivorans (49) (Sup-
plementary Figure S7) andRdhA fromNitratireductor paci-
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Figure 2. Structure and electrochemistry of QueG from Bacillus subtilis. (A) Ribbon depiction of QueG with the N-terminal Cbl-binding domain colored
with blue helices and purple -strands, the Fd-domain in gray and the RNA-binding domain in red. Inserts into the protein sequence that are described
in text are indicated with arrows. (B) Cofactor binding in QueG. Cbl, iron sulfur clusters and glycerol (from crystallization buffer) are shown in sticks,
colored as follows: carbon, yellow; oxygen, red; nitrogen, blue; cobalt, pink sphere; iron, ruby; sulfur, yellow; phosphorus, orange. His106 and Arg141 are
in blue sticks. Dashed magenta lines indicate hydrogen bonds, whereas gray dashed lines are used to indicate important distances between the cofactors.
(C) Cyclic voltammogram of the two [4Fe-4S] clusters in QueG. QueGwas deposited on a PGE electrode, with the baseline response of the electrode shown
as the dashed line. The baseline-corrected data are shown as the inset, with the fitting for the two one-electron centers displayed in dotted lines. Data were
collected at 100 mV/s, pH 8, 200 mM NaCl and 10◦C.
ficus pht-3B (50). In all cases, Cbl is bound in an ex-
tended mode with the dimethylbenzimidazole displaced as
the lower ligand to the cobalt (Figure 2 and Supplemen-
tary Figure S5C). Instead of a histidine serving as the lower
ligand, as is often the case in Cbl-binding proteins (51,52),
the lower axial position of the cobalt is vacant. In QueG,
access of water or other small ligands to the lower axial po-
sition appears to be blocked by Arg141, which is positioned
4 A˚ below the corrin ring with its guanidino group parallel
to the corrin ring. In CblC, a glutamine occupies this posi-
tion (Supplementary Figure S6), and in PceA, the Cbl tail
itself is rotated further under the corrin ring blocking access
(Supplementary Figure S7).
The Fd-domain of QueG is similar to the ferredoxin
from Clostridium acidurici (Supplementary Figure S8) (53)
and to the Fd-domains of RDH enzymes (Supplementary
Figure S7). The most notable differences are the presence
of inserts in QueG, one in the Cbl-binding domain and
one insert in the Fd-domain, which appear to be respon-
sible for creating a platform on which the RNA-binding
domain can reside (Supplementary Figure S5–S8). The
[4Fe-4S] clusters of QueG are coordinated by a cysteine-
rich motif, ‘Cys188-X2-Cys191-X2-Cys194-X3-Cys198-Xn-
Cys214-Xm-Cys240-X2-Cys243-X3-Cys247’ (19). Cys198,
Cys214, Cys240 and Cys243 bind the cluster proximal to
Cbl (termed cluster A), and Cys188, Cys191, Cys194 and
Cys247 bind a distal cluster (termed cluster B). Both clus-
ters are solvent accessible, and cluster A is only 4.0 A˚ from
a propionamide side chain of the corrin ring and 8.7 A˚ to
the cobalt center, whereas cluster B is positioned 9.5 A˚ from
clusterA (Figure 2B). This positioning is conserved inRDH
enzymes.
Protein film electrochemistry reveals that the QueG fold sta-
bilizes low-potential iron–sulfur clusters
The positioning of the [4Fe-4S] clusters in the structure
suggests that they provide a route for electrons from the
protein surface to the Cbl, indicating a role in Cbl reduc-
tion. However, Cbl has notoriously low redox potentials for
the Co2+/Co1+ couple, (approximately −530 to −610 mV)
(54), raising the question of whether the cluster potentials
are low enough to reduce the Cbl to the supernucleophile,
cob(I)alamin, state. Here, we used protein film electrochem-
istry (PFE) to investigate the redox potentials of the QueG
clusters. PFE of QueG on a PGE electrode displays a single,
reversible feature in the cyclic voltammogram that is very
broad with a peak width at half-height of ∼150 mV (Fig-
ure 2C). This feature is much broader than that expected
for a single one-electron center (86 mV at 10◦C), and is in-
stead consistent with two one-electron centers, such as two
[4Fe-4S] clusters, with reduction potentials of -575 mV and
−510 mV (versus SHE) at pH 8. These potentials are lower
than the potential of approximately −480 mV reported for
the two [4Fe-4S] clusters in one RDH,Dehalobacter restric-
tus tetrachloroethene reductase; however, these data for an
RDH were merely an estimate, as a complete titration was
not obtained (25). The lower potentials determined here for
B. subtilis QueG are closer to what one would expect for
clusters that are capable of reducing Cbl.
tRNA anticodon stem loop binds QueG with the wobble base
inserted deep into active site cavity
To investigate how QueG interacts with substrate, three
structures of QueG bound to RNA have been obtained
(Supplementary Table S2). In each case, a 17-mer tRNA
ACSL construct was used that is a known substrate of
QueG and displays the nucleotide sequence of E. coli
tRNATyr (Figure 1B and Supplementary Figure S3) (19,22).
Although the substrate specificity of QueG has not yet been
assessed quantitatively, it is known to process oQ to Q in
both this 17-mer ACSL construct and in bulk RNA sam-
ples from a QueG knockout strain (19).
A 2.1 A˚ resolution structure of QueG with RNA has
four molecules in the asymmetric unit, two of which have
electron density for RNA. However, in neither molecule is
the ACSL intact (Figure 3A and B). These structural data
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Figure 3. RNA binding to QueG. (A) A 2.10 A˚ resolution structure of
QueG (colored as in Figure 2A) co-crystallized with an unmodified ACSL
shows RNA (green backbone with green bases) bound to the C-terminal
HEAT-like domain. RNA is apparently cleaved; Q-34 toA-37 of theACSL
are not observed. (B) SigmaA-weighted composite omit (2mFo-DFc) elec-
tron density for the RNA shown in panel A, displayed at 1 level. (C)
A 2.65 A˚ resolution structure of QueG bound to an intact ACSL. (D)
SigmaA-weighted composite omit (2mFo-DFc) electron density for the
RNA shown in panel C, displayed at 1 level. (E) Bases of the intact ACSL
(green) are shifted by one base pair toward the active site compared to
structure of QueG with cleaved ACSL (dark gray). Black arrows point to
bases in the cleaved RNA structure (from panel A) and green arrows point
to bases from intact RNA structure (from panel C). (F) Predicted bind-
ing of full length tRNA, modeled by superposition of bacterial tRNATyr
(PDB accession code 3UZ6), shown in gray, with the modified and intact
ACSL (green) bound to QueG.
confirmed our expectation that the C-terminal HEAT-like
domain would serve to mediate enzyme:nucleotide interac-
tions, as we find nucleotides of the ACSL (G-27 to U-33)
nicely ordered against the HEAT-like domain, with the pro-
tein making direct hydrogen-bonds to the phosphates of
the phosphodiester backbone (Figure 3A and B and Sup-
plementary Figure S9A). The antisense strand (A-38 to C-
43) is also present in the structure, with contacts between
these nucleotides and protein involving crystal packing ex-
clusively (Supplementary Figure S9B). The anticodon loop
is completely disordered and is likely cleaved (see Materials
and Methods). Another structure, which is at lower resolu-
tion (2.65 A˚), also contains cleaved RNA. These two struc-
tures of QueG bound to a cleaved ACSL are very similar
to one another, except for the fact that a loop near the Cbl
has an altered position in the 2.65 A˚ resolution structure
(Supplementary Figure S10A). Both are also very similar
to the QueG structure without RNA (Supplementary Fig-
ure S10B).
The third structure was obtained by co-crystallization of
QueG with an oQ-modified ACSL under conditions that
minimized RNase contamination (see Materials andMeth-
ods), and the ACSL is intact (Figure 3C and D). Again,
little movement of the protein is observed, even compared
to the structure without any RNA substrate bound (Sup-
plementary Figure S10C). This result is in contrast with
many other Cbl-dependent enzymes for which large-scale
conformational changes upon substrate binding are a hall-
mark (51). In terms of RNA binding, this structure shows
that the tRNA ACSL is sufficiently large to bury all of the
highly positively charged surface on QueG (Supplementary
Figure S9C), although modeling suggests that a full-length
tRNATyr molecule could make additional contacts with
smaller patches of positively charged surface (Supplemen-
tary Figure S9D). Comparison of partial and intact ACSL-
bound QueG structures shows contacts to the same region
of the QueG RNA-binding domain (Figure 3A–D). How-
ever, bases of the intact ACSL are shifted by one base pair
toward the active site (fromblack arrow to green arrowposi-
tion in Figure 3E). Interestingly, although the substrate, oQ-
modified ACSL, was added to the co-crystallizations, elec-
tron density suggests turnover occurred, yielding a structure
that is largely of the Q-containing product tRNA (Supple-
mentary Figure S4A and B).
These structural data further show the interactions of
the ACSL with QueG that position oQ/Q in the active site
(Figure 4A and B, and Supplementary Table S3). Given
that QueG acts on four tRNAs, with only positions oQ-
34 and U-35 conserved, and A, U, G or C occupying po-
sition 36 (Supplementary Figure S3), we only expected to
find specific interactions between QueG and the anticodon
at positions 34 and 35, and that is exactly what we ob-
serve. In particular, the carbonyl at atom C4 of U-35 acts
as a hydrogen bond acceptor with Arg295 and Lys222 from
the QueG RNA-binding domain and the Fd-domain inser-
tion sequence, respectively (Figure 4A and Supplementary
Figure S11A and B). Cytosine at this position would be
less favorable than uracil, with a hydrogen bond donating
amino group replacing the hydrogen bond accepting car-
bonyl at C4, whereas purine bases would be too large to
occupy this binding site (Supplementary Figure S11C). As
expected, RNA base A-36 does not interact directly with
the protein, explaining how all four bases can be accom-
modated at this position. Instead of contacting protein, A-
36 appears to interact with U-35 of the ACSL by making a
Hoogsteen hydrogen-bonding interaction from its exocyclic
amine with the C2 carbonyl of U-35 (2.9 A˚), and a non-
hydrogen-bonding close contact (2.9 A˚) between the N7 ni-
trogen of A-36 and the C2 carbonyl of U-35 (Figure 4A).
Notably in a fully modified bacterial tRNATyr, A-37 would
be modified with both a prenylation and methylthiolation
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Figure 4. ACSL conformation and QueG interactions. (A) Close-up view
of U-35 and A-36 of the QUN anticodon bound to QueG. Hydrogen-
bonding and close van der Waals interactions are displayed as dashed
cyan and black lines, respectively. (B) Zoom-in of Q binding within QueG
with van der Waal radii displayed as spheres and protein residues colored
by domain. Dashed lines are defined in panel A. (C) Stereoview of the
non-canonical ACSL conformation observed in theQueG co-crystal struc-
ture. (D) Stereoview of the ACSL in classic ‘U-turn’ from a full tRNATyr
molecule bound within the ribosome from Thermus thermophilus (PDB
accession code 4V8D), which contains the ms2i6A-37 modification (rep-
resented with purple colored carbons). (E) Surface cut-away representa-
tion of QueG active site showing shape complementarity for the extended
Q-base. (F) Two conformations of the Asp134-loop could facilitate the
requisite ACSL rearrangements and the insertion of oQ into active site:
an ‘open-loop’ conformation as observed in the 2.65 A˚ resolution QueG
structure with a cleaved ACSL (carbons in green) and a ‘closed-loop’ con-
formation as observed in the intact ACSL QueG structure (carbons in yel-
low).
to yield ms2i6A-37, and we find a glycerol molecule occupy-
ing this space left empty by the lack of these modifications
(Supplementary Figure S11A).
Q itself buries considerable surface area (240 A˚2) as it ex-
tends into the QueG active site cavity (Figure 4B and E).
The deazaguanine moiety of Q-34 is at the top of the active
site, sandwiched between Trp294 of the RNA-binding do-
main and Thr135 of the Cbl-binding domain, andmaking a
water-mediated hydrogen bond to Tyr238 of the Fd-domain
(Figure 4B). The aminomethyl–cyclopentenediol moiety of
Q transverses deeper into the active site and is rotated such
that its amino group is 2.5 A˚ from the carbonyl of the deaza-
guanine base, allowing for the possibility of a favorable in-
tramolecular hydrogen-bonding interaction (Figure 4B and
Supplementary Figure S12C). The cyclopentenediol group
is bound at the bottom of the active site, ∼4 A˚ from the Cbl
cobalt. Although Q makes few hydrogen bonds to QueG,
specificity for the oQ base versus an unmodified one can
be explained by the depth of the active site cavity; an un-
modified base would be too far from the Cbl for any reac-
tion to occur (∼10 A˚) and the differential in binding sur-
face of the Q- versus G-base in this site (240 A˚2 versus 124
A˚2) would result in a weaker interaction of QueG with a
tRNA containing an unmodified G in its anticodon (Fig-
ure 4E). When substrate is bound to QueG, both the upper
axial water ligand to the Cbl and the crystallographic glyc-
erol molecule are displaced (Supplementary Figure S12A–
C). Refinement of the Q-base places the double bond of
the cyclopentenediol 3.0 A˚ from Asp134, whereas one of
the two cyclopentenediol hydroxyls is in hydrogen-bonding
distance of Gln220 (2.9 A˚) and the other is packed against
Phe49 (Figure 4B). Assuming the substrate oQ binds sim-
ilarly, Gln220 likely orients the ring structure for catalysis,
whereas Asp134 would be in position to interact with the
epoxy moiety, functioning perhaps as a catalytic acid (see
Discussion).
QueG-bound ACSL has twists but no U-turns
The QueG bound-ACSL has undergone considerable re-
modeling and does not display the canonical ‘U-turn’ struc-
ture, i.e. the sharp reversal of the RNA backbone that is
commonly associatedwith the positioning of the three bases
of the anticodon for codon:anticodon base-pairing during
protein synthesis (55) (Figure 4C and D). In a classic U-
turn, as observed in the ribosome-bound tRNATyr structure
(56), the anticodon bases G-34–U-35–A-36 are on one side
of the turn, stacked with each other, and bases U-33, C-32
and A-31 are on the other side of the turn, also stacked. U-
33 stabilizes this almost 180◦ reversal in direction by hydro-
gen bonding across the turn to a backbone phosphate. Sim-
ilar to the tRNATyr-ribosome complex, our structure shows
bases U-33, C-32 and A-31 stacked upon each other. How-
ever, all the anticodon bases (Q-34, A-36, U-35) and A-37
have altered positions and interactions, with the net result
being thatU-33 now stabilizes a broad rather than tight turn
that positions Q-34 in the active site (Figure 4C and D).
If we consider other enzymes that modify tRNA at posi-
tion 34 for which there are co-crystal structures (57–60), we
find that the ACSL is commonly splayed open rather than
adopting the U-turn configuration (Supplementary Figure
Nucleic Acids Research, 2016, Vol. 44, No. 20 9973
S13). Although most ACSLs have undergone a fairly large
conformational change, none of the conformations resem-
ble that found in QueG, and none truly resemble each other.
It is impressive how many different loop conformations are
possible, which is a feature of RNA structure that is likely
essential for specificity of protein–RNA and RNA–RNA
recognition.
The tight fit of the Q base into the deep active site cav-
ity raises the question of how the modified base gets in
there. The QueG active site cavity is designed to bind a
broad anticodon turn with the Q base already splayed out
and not the U-turn configuration of the ACSL (Figure 4).
This active site design suggests that the ACSL conforma-
tional change should occur prior to QueG binding. How-
ever, chemical logic suggests that protein binding should fa-
cilitate the requisite ACSL conformational change, making
a case for protein binding as the first step. Here, the various
crystallographic snapshots provide insight. The 2.10 A˚ res-
olution structure of QueG with a cleaved ACSL shows that
RNA can form non-specific interactions with QueG even
in the absence of any specific anticodon loop-protein inter-
actions, suggesting that the first step could be non-specific
RNA–protein interactions made by protein residues from
the HEAT domain that are outside of the active site. This
non-specific binding of the ACSL to QueG would also po-
sition the anticodon loop near the enzyme active site (Fig-
ure 3). The 2.65 A˚ resolution structure of QueG with a
cleaved ACSL shows that a conformationally flexible loop
(the Asp134-loop) can flip out to generate an open active
site (Figure 4F and Supplementary Figure S14A–C). Such
an open active site could accommodate a U-turn configu-
ration of the ACSL, which would need to undergo a con-
formational change prior to, or along with, the movement
of the Asp134-loop back into the active site to assume the
catalytic conformation of the protein that we observe in
the structure of QueG with an intact ACSL. Importantly,
the sequence of the anticodon would need to be correct
for this active site closure to occur, both to satisfy the hy-
drogen bonding requirements described above and for the
packing considerations described above and here. Thus, this
set of structures predicts that non-specific interactions be-
tween the RNA and enzyme occur first, facilitating confor-
mational changes of both the ACSL and one protein loop
to afford a specific and tight complex between the enzyme
active site and the oQ base. In this way, the splayed out base
serves two purposes: ensuring specificity and also allowing
for the appropriate juxtaposition of cofactor and substrate
to afford catalysis.
DISCUSSION
Although the Q modification was discovered 47 years ago
(7), its biosynthetic pathway was not fully established un-
til recently (16–21), and though Cbl was proposed to be
involved (26), the role that it played and the form of Cbl
involved were not known. The structures and electrochem-
istry presented here provide new insight into the role of Cbl
as well as the mechanism of oQ reduction.
We find that the ACSL binds QueG within a protein
cavity located at the interface of the Cbl-binding, Fd- and
RNA-binding domains, such that Q-34 is positioned di-
rectly above the Cbl. This juxtaposition of cofactor and
product is consistent with a direct role of the cofactor in
product formation. In particular, we propose (Figure 5) that
the nucleophilic attack of cob(I)alamin on oQ leads to for-
mation of a cob(III)alamin-substrate intermediate adduct,
which dissociates upon reduction and protonation to form
cob(II)alamin and the product Q. Such chemistry has prece-
dence; cob(I)alamin is known to react with epoxides in
solution, forming stable -hydroxyalkylcobalamin adducts
(61,62). Although the distance that we observe between the
Q base and Cbl (4 A˚) is appropriate for a product com-
plex, we would expect the substrate oQ to be closer to the
Cbl (∼3.5 A˚) for the nucleophilic attack of cob(I)alamin
and that covalent attachment would require an even closer
distance (∼2.3 A˚). Modeling shows that a small rotation
around the substrate aminomethyl linker and translation of
the nucleoside down toward the Cbl can generate these ex-
pected distances without any major change in the protein
structure or loss of hydrogen bonding contacts to protein
(Supplementary Figure S15). Thus, a covalent mechanism
appears consistent with the active site architecture.
Our structural work has captured both the initial state of
the enzyme without substrate and the final state with prod-
uctQbound (Figure 5). FromEPR,we know that substrate-
freeQueG is in the cob(II)alamin state, with g- andA-values
supporting a 5-coordinate Cbl in which the fifth coordi-
nation position is occupied by a water molecule (22). Our
structure shows 5-coordinate Cbl with water as the upper
axial ligand and no lower ligand. For nucleophilic attack on
an epoxide, Cbl would need to be reduced by one electron to
the +1 state (Figure 5), and the structure shows two [4Fe-4S]
clusters positioned ideally for electron transfer to the Cbl
at 8–9 A˚ apart. Although reduction of 5-coordinate Cbl is
challenging for biological reductants due to cob(I)alamin’s
low midpoint potential (approximately −530 to −610 mV)
(54), PFE presented here shows that these clusters are also
low in potential (−575 mV and −510 mV) and thus well
suited for this function. Arg141 is observed to block access
to the lower face Cbl, which may preorganize the cofac-
tor for reduction to a square-planar cob(I)alamin species,
the preferred geometry for cob(I)alamin (54). Expression of
an Arg141Ala QueG variant in an E. coli queG knockout
strain significantly reduces the Q-content of the strain com-
pared to wild-type, suggesting that limiting access to the
lower face of Cbl is important for QueG activity (22). The
upper water ligand observed in the initial structure would
either dissociate upon substrate binding or be released upon
reduction of the Cbl. A number of solvent binding sites are
available near the cofactor that could provide a route to
or from the Cbl cobalt (Supplementary Figure S12). Alter-
natively, movement of the Asp134-loop, as observed in the
2.65 A˚ resolution structure of QueG with a cleaved ACSL,
could be responsible for releasing water molecules as sub-
strate binds.
A potential caveat with this mechanistic proposal (Fig-
ure 5) is that -hydroxyalkylCbls, such as the one proposed
to form in this scheme, tend to be relatively stable. However,
model chemistry indicates that protonation can decrease the
stability of such adducts and facilitate Co-C bond cleavage
and product release. Most relevant to QueG, -hydroxy-
substituted Cbl model systems are known to undergo acid-
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Figure 5. A proposed mechanism. Based on QueG structures as well as mutagenesis data (22), Asp134 is predicted to serve as the general acid catalyst.
catalyzed Co-C bond cleavage (63). For QueG, protonation
of the epoxide oxygen, either before or after ring opening,
would be expected to facilitate Co-C bond heterolysis, re-
leasing the product. Our structure shows that Asp134 is ide-
ally located to protonate the epoxide oxygen. Consistent
with such a function, an Asp134Ala variant in a queG
knockout strain dramatically decreases Q production (22).
Additionally or alternatively to acid catalyzed Co-C cleav-
age of an alkylCbl intermediate, a 1-electron reduction of
alkylCbl is known to destabilize the C-Co bond in solution
(54).
Overall, the mechanistic proposal in Figure 5 requires
two protons and two electrons to reduce the epoxide oxy-
gen to water. As mentioned above, Asp134 is positioned
such that it could carry out both the protonation of the
epoxide oxygen, facilitating the ring opening and the pro-
tonation of the resulting hydroxide, facilitating adduct re-
lease from Cbl and loss of water. Importantly, Asp134 hy-
drogen bonds to His106, which is near the surface of the
protein, and could provide a conduit for protons into a
closed active site. As with Asp134, mutation of His106 to
Ala substantially affects Q production in a queG knock-
out strain, indicating that it plays an important catalytic role
(22). Given that a neutral, rather than negatively charged,
Asp134 shouldmake it easier to reduce theCbl, protonation
of Asp134 and electron transfer to Cbl may be correlated,
if not specifically coupled. As mentioned above, the vehi-
cle for electron delivery to Cbl is immediately obvious from
the structure, which shows two [4Fe-4S] clusters adjacent to
Cbl. The importance of these clusters to QueG activity was
confirmed throughmutagenesis of the Cys coordinating lig-
ands to Ala, all but one of which results in complete loss of
Q production in vivo (22).
Data from these and other (27,49,50) structural and bio-
chemical studies of QueG and RDHs are serving to ex-
pand the known reactivity of the Cbl cofactor and of Cbl-
dependent enzymes. They also underscore the importance
and prevalence of a previously under-appreciated third class
of Cbl-dependent enzymes, ones that do not use MeCbl or
AdoCbl in their chemistry (29). In terms of defining this
class, it does appear that the lack of an upper ligand is func-
tionally important to allow for a Cbl with a free upper posi-
tion to form covalent adducts with substrate, as we propose
here, and/or facilitate product release as has been suggested
for some members of the RDH family (49,50). Thus, the
relevant forms of Cbl are: MeCbl, AdoCbl, and open-Cbl.
Cbl, often referred to as Nature’s most beautiful cofactor
(64), continues to offer up more incredible chemistry as we
continue to discover its secrets.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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